Analysis of patient NSCLC tissue concluded that CCR7 and CCL21 levels correlated with VEGF-D expression, lymphatic vessel density, higher clinical stages, lymph node metastasis and decreased patient survival [211]. This evidence concerns the gene CCR7 and metastatic malignant neoplasm in the lymph nodes.